H-1B sponsorship profile: Nexus Pharmaceuticals Inc. Across U.S. Department of Labor LCA disclosures, Nexus Pharmaceuticals Inc filed 9 Labor Condition Applications covering 9 H-1B worker positions between fiscal year 2023 and fiscal year 2025. The employer’s DOL certification rate sits at 88.9% (8 certified of 9 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Nexus Pharmaceuticals Inc’s H-1B petitions range from $75,000 at the low end to $164,800 at the high end, with a petition-weighted average of $109,860. That range reflects the mix of occupations the company sponsors, led by Formulation Scientist II (3 petitions at $92,894 avg), followed by Analytical Scientist III and Technical Transfer Associate. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Nexus Pharmaceuticals Inc is headquartered in Lincolnshire, IL under NAICS code 325412, and places H-1B workers across 1 state, most heavily in IL. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Nexus Pharmaceuticals Inc ranks. By H-1B petition volume, Nexus Pharmaceuticals Inc is #17,879 of 119,880 employers nationally and #879 of 5,284 employers headquartered in IL. Both ranks are computed live from the same underlying petition counts, not a separate estimate.